Breast Biopsy Device Market Report: Trends, Forecast and Competitive Analysis to 2030

Breast Biopsy Device Trends and Forecast

The future of the global breast biopsy device market looks promising with opportunities in the hospital & clinic, research laboratory, and pharmaceutical & biotechnology markets. The global breast biopsy device market is expected to reach an estimated $2.1 billion by 2030 with a CAGR of 5.2% from 2024 to 2030. The major drivers for this market are growing incidence of breast cancer, significant use of this device to enable less intrusive techniques, and rising preference for liquid biopsy.

A more than 150-page report is developed to help in your business decisions.

Breast Biopsy Device by Segment

The study includes a forecast for the global breast biopsy device by type, procedure, application, end use, and region.

Breast Biopsy Device Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Biopsy Needles
• Guidance Systems
• Biopsy Tables
• Localization Wires
• Assay Kits
• Liquid Biopsy Instruments
• Others

Breast Biopsy Device Market by Procedure [Shipment Analysis by Value from 2018 to 2030]:

• Needle Breast Biopsy
• Open Surgical Breast Biopsy
• Liquid Breast Biopsy

Breast Biopsy Device Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Early Cancer Screening
• Therapy Selection
• Treatment Monitoring
• Recurrence Monitoring

Breast Biopsy Device Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals & Clinics
• Research Laboratories
• Pharmaceutical & Biotechnology Companies
• Others

Breast Biopsy Device Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Breast Biopsy Device Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies breast biopsy device companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the breast biopsy device companies profiled in this report include-

• Hologic
• Danaher
• Argon Medical Devices
• Merit Medical Systems
• Menarini-Silicon Biosystems
• Guardant Health
• Neogenomics
• Sysmex Inostics
• Sterylab
• Biocept

Breast Biopsy Device Market Insights

Lucintel forecasts that guidance system is expected to witness highest growth over the forecast period due to its significant use in enhancing the accuracy and efficiency of biopsy procedures.

Hospital will remain the largest segment due to the rising adoption of advanced diagnostic tools and skilled professionals to improve patient care in this setting.

North America is expected to witness highest growth over the forecast period due to rising breast cancer cases, availability of attractive reimbursement opportunities, and presence of robust healthcare infrastructure in the region.

Features of the Global Breast Biopsy Device Market

Market Size Estimates: Breast biopsy device market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Breast biopsy device market by various segments, such as by type, procedure, application, end use and region in terms of($B).

Regional Analysis: Breast biopsy device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, procedures, applications, end uses, and region.s for the breast biopsy device market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the breast biopsy device market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the breast biopsy device market size?

Answer: The global breast biopsy device market is expected to reach an estimated $2.1 billion by 2030.

Q.2. What is the growth forecast for breast biopsy device market?

Answer: The global breast biopsy device market is expected to grow with a CAGR of 5.2% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the breast biopsy device market?

Answer: The major drivers for this market are growing incidence of breast cancer, significant use of this device to enable less intrusive techniques, and rising preference for liquid biopsy.

Q.4. What are the major segments for breast biopsy device market?

Answer: The future of the breast biopsy device market looks promising with opportunities in the hospital & clinic, research laboratory, and pharmaceutical & biotechnology markets.

Q.5. Who are the key breast biopsy device market companies?

Answer: Some of the key breast biopsy device companies are as follows:

• Hologic
• Danaher
• Argon Medical Devices
• Merit Medical Systems
• Menarini-Silicon Biosystems
• Guardant Health
• NeoGenomics
• Sysmex Inostics
• Sterylab
• Biocept

Q.6. Which breast biopsy device market segment will be the largest in future?

Answer: Lucintel forecasts that guidance system is expected to witness highest growth over the forecast period due to its significant use in enhancing the accuracy and efficiency of biopsy procedures.

Q.7. In breast biopsy device market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to rising breast cancer cases, availability of attractive reimbursement opportunities, and presence of robust healthcare infrastructure in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the breast biopsy device market by type (biopsy needles, guidance systems, biopsy tables, localization wires, assay kits, liquid biopsy instruments, and others), procedure (needle breast biopsy, open surgical breast biopsy, and liquid breast biopsy), application (early cancer screening, therapy selection, treatment monitoring, and recurrence monitoring), end use (hospitals & clinics, research laboratories, pharmaceutical & biotechnology companies, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?